CASI News and Press, CASI Pharmaceuticals Inc. From 04/30/21

Analysts Say These Penny Stocks Are A Buy. Do You Agree? If you’re looking for penny stocks to buy, there are plenty of ways to find them. You could sift through hundreds of charts. There’s also plenty of news and corporate filings to look at. Maybe you want to find top ...

Scienjoy Holding Corporation SJ +29% on launching Non-Fungible Tokens on its platforms.MICT (MICT) +17%.Ocugen (OCGN) +15%.BrainsWay BWAY +14% on FDA clearance for Deep TMS protocol.China Recycling Energy (CREG) +13%.Axsome Therapeutics AXSM +12% on FDA acceptanc...

CASI Pharmaceuticals (CASI) has added ~8.0% in the pre-market after its Chairman/CEO Wei-wu He disclosed the purchase of 3M company shares in a regulatory filing submitted yesterday.Making the company’s first insider transaction for the year, Wei-wu He has bought 3M...

Penny Stocks Are Risky But Have Far Outperformed Blue-Chips In 2021 There’s no secret that penny stocks are high-risk. But there’s something about these cheap stocks that give a sense of excitement. There are few places where you can buy something for $100 1 day and se...

Arcadia Biosciences RKDA +37% on Q4 results.ProPhase Labs PRPH +31% on VaccTrack acquisition.ClearOne CLRO +19% on Q4 results.Taoping TAOP +17% on share purchase agreement with Genie Global Limited.SPAR Group SGRP +16% on Q4 results.Greenlane ...

CASI Pharmaceuticals (CASI): FY GAAP EPS of -$0.44 misses by $0.06.Revenue of $15M (+263.2% Y/Y) beats by $0.31M.Shares +1.01% PM.Press Release For further details see: CASI Pharmaceuticals EPS misses by $0.06, beats on revenue

CASI Pharmaceuticals Announces Full Year 2020 Financial Results PR Newswire ROCKVILLE, Md. and BEIJING , March 30, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing...

4 Biotech Penny Stocks For You End Of March Watch List Whether you’re a big fan of penny stocks or you’re trying to avoid them at all costs, there’s no denying the potential they have. There are very few things you can invest your money in and see quick & large ...

CASI Pharmaceuticals (NASDAQ: CASI) was down by roughly 15% in late trading on Wednesday, against the more or less flat performance of the S&P 500 index. The catalyst is the company's pricing of a relatively large and dilutive public issue of new stock. CASI announced We...

CASI Pharmaceuticals (CASI) trades 12.7% down premarket after pricing its earlier announced underwritten public offering of 15.8M shares at $2.05/share; underwriters granted 30-day option to purchase up to an additional 2.38M shares.Offering is expected to close on or abou...